SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-147891
Filing Date
2021-12-09
Accepted
2021-12-09 08:15:31
Documents
16
Period of Report
2021-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134794d1_8k.htm   iXBRL 8-K 31623
2 EXHIBIT 10.1 tm2134794d1_ex10-1.htm EX-10.1 1018245
3 EXHIBIT 99.1 tm2134794d1_ex99-1.htm EX-99.1 15201
7 GRAPHIC tm2134794d1_ex10-1img001.jpg GRAPHIC 6059
8 GRAPHIC tm2134794d1_ex99-1img001.jpg GRAPHIC 5159
  Complete submission text file 0001104659-21-147891.txt   1483414

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pcrx-20211206.xsd EX-101.SCH 3019
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcrx-20211206_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcrx-20211206_pre.xml EX-101.PRE 22355
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2134794d1_8k_htm.xml XML 3610
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 211480321
SIC: 2834 Pharmaceutical Preparations